Most recently, it has been determined that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable parts as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger and would not activate a second